NHS
Office Depot
Novartis
Northwestern Mutual
Nordea
Nintendo
Nike
New Balance
Neuberger Berman
Netflix
Nestle
NBCU
Navy Federal Credit Union
Natwest
Nationwide
National Geographic
MUFG
Naspers
Nandos
Morrisons
Morgan Stanley
Monzo
Mondelez
Milwaukee
Micron
Michelin
MGM
Metlife
Ebay
McLaren
McDonalds
Mattel
Mastercard
Marshall
Mars
Marriott
Marks and Spencer
Market Basket
Makita
Maersk
Macy's
Lufthansa
Lowes
Lockheed Martin
Lloyds Bank
Linde
Lidl
Levis
Leica
Lego
Legal and General
Land o Lakes
Loreal
Kroger
Krispy Kreme
KraftHeinz
Kohls
KKR
KitchenAid
Kappa
King
KFC
KeyBank
Kelloggs
Keller Williams
Kawasaki
Just Eat
JP Morgan Chase
Jordan
Johnson and Johnson
John Lewis
Jersey Mikes
Jaguar
ITV
Instagram
ING
In N Out
IKEA
IHG
Hulu
HSBC
Hewlett Packard Enterprise
Home Depot
Hinge
Hershey
Hermes
Hellman
Harley Davidson
HEB
HBO
Hawaiian Airlines
Hasbro
Harrods
Harper Collins
Hardees
Halifax
Haagen Dazs
H&M
Groupon
Grant Thornton
NHS
Office Depot
Novartis
Northwestern Mutual
Nordea
Nintendo
Nike
New Balance
Neuberger Berman
Netflix
Nestle
NBCU
Navy Federal Credit Union
Natwest
Nationwide
National Geographic
MUFG
Naspers
Nandos
Morrisons
Morgan Stanley
Monzo
Mondelez
Milwaukee
Micron
Michelin
MGM
Metlife
Ebay
McLaren
McDonalds
Mattel
Mastercard
Marshall
Mars
Marriott
Marks and Spencer
Market Basket
Makita
Maersk
Macy's
Lufthansa
Lowes
Lockheed Martin
Lloyds Bank
Linde
Lidl
Levis
Leica
Lego
Legal and General
Land o Lakes
Loreal
Kroger
Krispy Kreme
KraftHeinz
Kohls
KKR
KitchenAid
Kappa
King
KFC
KeyBank
Kelloggs
Keller Williams
Kawasaki
Just Eat
JP Morgan Chase
Jordan
Johnson and Johnson
John Lewis
Jersey Mikes
Jaguar
ITV
Instagram
ING
In N Out
IKEA
IHG
Hulu
HSBC
Hewlett Packard Enterprise
Home Depot
Hinge
Hershey
Hermes
Hellman
Harley Davidson
HEB
HBO
Hawaiian Airlines
Hasbro
Harrods
Harper Collins
Hardees
Halifax
Haagen Dazs
H&M
Groupon
Grant Thornton

Register your Interest:

Leading Together: Reimagining Clinical Development in the Age of AI - Pt 2

Events

>

Upcoming

Past

>

Leading Together: Reimagining Clinical Development in the Age of AI - Pt 2

Roundtable
Leading Together: Reimagining Clinical Development in the Age of AI - Pt 2

Speakers

Sarah Tijou

Sarah is a creative, people-first leader who’s spent her career using the power of storytelling to connect, inspire, and drive change. As Senior Vice President at Panelle, she helps global brands team up with standout leaders - especially women rewriting the rules - to build smarter, more inclusive futures. Her work is all about unlocking fresh perspectives and helping the next generation rise. Before this, Sarah made her mark in media - leading content and news teams at BBC Radio 1, BBC World Service, Global Radio, and ITN. Whether behind the mic or behind the scenes, she focused on telling stories that mattered, sparking conversation, and making people think. That same passion for meaningful storytelling still drives her today. With a unique blend of editorial instinct and strategic vision, Sarah continues to champion bold ideas and the people behind them, always with an eye on what’s next!

Sarah Tijou

Senior Vice President

Panelle

Moderator

Simone Sharma

Simone Sharma has been working on solutions for data access, integration and advanced analytics within clinical research for almost a decade. In her current role as the Lead Clinical Product Manager, Simone is focused on building innovative Clinical Analytics solutions by converting business objectives into tangible products. Her previous roles have included Strategic Lead for Translational Analytics and Snr. Data Analytics Application Specialist at Revvity Signals (formerly PerkinElmer Informatics). Prior to that, she held Application Specialist roles (in Genomics) at Integromics and UCL.

Simone Sharma

Product Leader, Clinical

Revvity Signals

Partner

Christie Quarles

Christie is a Clinical Product Marketing Manager at Revvity Signals. She brings over 20 years of leadership in life sciences and clinical analytics to her role. As a seasoned product leader with deep experience in clinical trials, real-world evidence, vaccine commercialization, and genomics, she has successfully shaped go-to-market strategies for global SaaS solutions in biotechnology and healthcare.

Christie Quarles

Senior Product Marketing Leader

Revvity Signals

Partner

Carol Ann Satler

Carol is a physician executive and biopharmaceutical leader with 20+ years of experience driving R&D, clinical development, and medical affairs across global organizations including Pfizer, Sanofi, Gilead, and Bayer. She has led global teams of 300+ and delivered NDA/MAA approvals and blockbuster launches across cardiovascular, respiratory, fibrosis, rare disease, and oncology portfolios. A strategic, Harvard-trained leader, she integrates cutting-edge science, AI-driven discovery, and operational excellence to deliver transformative therapies and global impact.

Carol Ann Satler

Senior Vice President Clinical Development

Insilico Medicine

Speaker

Meena Davuluri

Meena is a urologist and health policy leader with extensive experience in healthcare delivery, policy research, and cost-effectiveness analysis. She is passionate about improving the quality, efficiency, and equity of care for urologic patients. Currently an Associate Medical Director in U.S. Medical Affairs for Prostate Cancer at Bayer, she brings a data-driven approach to clinical strategy. She previously served as a Clinical Assistant Professor of Urology and Population Health Sciences at Weill Cornell Medicine, leading outcomes and equity initiatives and mentoring trainees.

Meena Davuluri

Associate Medical Director, US Medical Affairs

Bayer

Speaker

Iriny Salib

Iriny is a highly experienced and ambitious field medical affairs expert, with significant experience in immunizations and vaccine preventable infectious disease. The highlights of her skills and experience include extensive skills as a clinical educator, accomplished presenter, and excellent communicator with strengths in leadership, strategic analysis, account management, field medical engagement, project management, innovation, and problem solving

Iriny Salib

Global Medical Director, GSK Vaccines

GSK

Speaker

Ronald Matteotti

Ronald Matteotti is a triple board-certified surgeon and Global Medical Affairs executive with over 20 years in healthcare. He currently leads global oncology initiatives at Bristol Myers Squibb, focusing on pancreatic and liver cancers, including major immunotherapy programs such as CheckMate 8HW, 9DW, and 9DX. His work integrates clinical leadership, evidence generation, digital health, and global strategy across the US, EU5, and APAC to advance patient-centered cancer care.

Ronald Matteotti

Global Medical Lead

Bristol Myers Squibb

Speaker

Carl DiCasoli

Experienced biostatistics professional with strong communication, people, and project management skills across all phases of clinical trials (Phase I, II, III, and IV). Involved in preparing multiple submissions to FDA/EMA, working with regulators and senior management with a strategic focus, and leading compounds / studies across many therapeutic areas simultaneously including cell therapy (CAR-T), anti-infectives, immunology, immuno-oncology, cardiovascular, respiratory, medical imaging, medical devices (Class I and Class III), Hepatitis C, rare disease (wAIHA, CAD, lupus, myositis, nephrology).

Carl DiCasoli

Head of Biometrics

Gan & Lee Pharmaceuticals

Speaker

Overview:

The future of clinical development will be defined not only by technological breakthroughs but by how teams rethink the way they work. As trials generate unprecedented data volume, velocity, and complexity, organisations are being challenged to evolve; shifting from manual, reactive processes to AI-enabled, insight-driven decision-making.

Whether you’re early in your journey or well-established in your approach, we’ll explore how AI is reshaping study operations, accelerating timelines, improving data quality, and strengthening cross-functional alignment between sponsors, CROs, and technology partners.

Rather than focusing on AI as a distant ideal, this discussion will uncover what it really takes to operationalise it: new oversight models, new ways of working, cultural transformation, strategic leadership, and the confidence to adopt human-in-the-loop systems responsibly.

Together, we will examine how organisations can build a more connected, transparent, and analytics-driven clinical environment. One where teams make faster decisions, reduce duplication, and unlock meaningful insights earlier in development.

Topics of Discussion:

1. What challenges are you currently facing when it comes to AI in clinical data work?

2. As AI becomes more involved in data review, what helps you feel confident in the decisions your teams make?

3. What would better collaboration between sponsors and CROs look like in your day-to-day work?

4. What would it take for your teams to move from reacting to data to really getting ahead of it?

5. As roles evolve, what kind of support - from mentors, peers, or leaders - helps you show up with confidence in this new AI-enabled environment

Join
the
Movement

The Panelle community exists for the women of today, but also the women of tomorrow. Join a group of likeminded executives, stakeholders, influencers and changemakers on their relentless journey to rebuild entrenched systems of inequality. By becoming a part of Panelle, you'll unlock access to exclusive content, interviews and discussions, all whilst blazing a trail for younger generations of women to come. If not now, then when?